BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36084484)

  • 1. ALS mutations in both human skeletal muscle and motoneurons differentially affects neuromuscular junction integrity and function.
    Badu-Mensah A; Guo X; Nimbalkar S; Cai Y; Hickman JJ
    Biomaterials; 2022 Oct; 289():121752. PubMed ID: 36084484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Skeletal Muscle-Specific Creatine Treatment on ALS NMJ Integrity and Function.
    Badu-Mensah A; Guo X; Mendez R; Parsaud H; Hickman JJ
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of Glial Cell at the Neuromuscular Junction Are Incompatible with Synaptic Repair in the
    Martineau É; Arbour D; Vallée J; Robitaille R
    J Neurosci; 2020 Sep; 40(40):7759-7777. PubMed ID: 32859714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Clark JA; Southam KA; Blizzard CA; King AE; Dickson TC
    J Chem Neuroanat; 2016 Oct; 76(Pt A):35-47. PubMed ID: 27038603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposite Synaptic Alterations at the Neuromuscular Junction in an ALS Mouse Model: When Motor Units Matter.
    Tremblay E; Martineau É; Robitaille R
    J Neurosci; 2017 Sep; 37(37):8901-8918. PubMed ID: 28821658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of ALS-linked SOD1 Mutation in Motoneurons or Myotubes Induces Differential Effects on Neuromuscular Function In vitro.
    Benlefki S; Sanchez-Vicente A; Milla V; Lucas O; Soulard C; Younes R; Gergely C; Bowerman M; Raoul C; Scamps F; Hilaire C
    Neuroscience; 2020 May; 435():33-43. PubMed ID: 32234507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional skeletal muscle model derived from SOD1-mutant ALS patient iPSCs recapitulates hallmarks of disease progression.
    Badu-Mensah A; Guo X; McAleer CW; Rumsey JW; Hickman JJ
    Sci Rep; 2020 Aug; 10(1):14302. PubMed ID: 32868812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromuscular Junction Dysfunction in Amyotrophic Lateral Sclerosis.
    Verma S; Khurana S; Vats A; Sahu B; Ganguly NK; Chakraborti P; Gourie-Devi M; Taneja V
    Mol Neurobiol; 2022 Mar; 59(3):1502-1527. PubMed ID: 34997540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynein disruption perturbs post-synaptic components and contributes to impaired MuSK clustering at the NMJ: implication in ALS.
    Vilmont V; Cadot B; Vezin E; Le Grand F; Gomes ER
    Sci Rep; 2016 Jun; 6():27804. PubMed ID: 27283349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipose-derived stem cell conditioned medium impacts asymptomatic peripheral neuromuscular denervation in the mutant superoxide dismutase (G93A) transgenic mouse model of amyotrophic lateral sclerosis.
    Walker CL; Meadows RM; Merfeld-Clauss S; Du Y; March KL; Jones KJ
    Restor Neurol Neurosci; 2018; 36(5):621-627. PubMed ID: 30010155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome analysis using patient iPSC-derived skeletal myocytes: Bet1L as a new molecule possibly linked to neuromuscular junction degeneration in ALS.
    Lynch EM; Robertson S; FitzGibbons C; Reilly M; Switalski C; Eckardt A; Tey SR; Hayakawa K; Suzuki M
    Exp Neurol; 2021 Nov; 345():113815. PubMed ID: 34310943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
    Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
    Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle Fibers Secrete FGFBP1 to Slow Degeneration of Neuromuscular Synapses during Aging and Progression of ALS.
    Taetzsch T; Tenga MJ; Valdez G
    J Neurosci; 2017 Jan; 37(1):70-82. PubMed ID: 28053031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small junction, big problems: Neuromuscular junction pathology in mouse models of amyotrophic lateral sclerosis (ALS).
    Alhindi A; Boehm I; Chaytow H
    J Anat; 2022 Nov; 241(5):1089-1107. PubMed ID: 34101196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of Impaired BDNF Signaling, Their Coupled Downstream Serine-Threonine Kinases and SNARE/SM Complex in the Neuromuscular Junction of the Amyotrophic Lateral Sclerosis Model SOD1-G93A Mice.
    Just-Borràs L; Hurtado E; Cilleros-Mañé V; Biondi O; Charbonnier F; Tomàs M; Garcia N; Lanuza MA; Tomàs J
    Mol Neurobiol; 2019 Oct; 56(10):6856-6872. PubMed ID: 30929165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FUS-mediated regulation of acetylcholine receptor transcription at neuromuscular junctions is compromised in amyotrophic lateral sclerosis.
    Picchiarelli G; Demestre M; Zuko A; Been M; Higelin J; Dieterlé S; Goy MA; Mallik M; Sellier C; Scekic-Zahirovic J; Zhang L; Rosenbohm A; Sijlmans C; Aly A; Mersmann S; Sanjuan-Ruiz I; Hübers A; Messaddeq N; Wagner M; van Bakel N; Boutillier AL; Ludolph A; Lagier-Tourenne C; Boeckers TM; Dupuis L; Storkebaum E
    Nat Neurosci; 2019 Nov; 22(11):1793-1805. PubMed ID: 31591561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TDP-43 dysregulation and neuromuscular junction disruption in amyotrophic lateral sclerosis.
    Lépine S; Castellanos-Montiel MJ; Durcan TM
    Transl Neurodegener; 2022 Dec; 11(1):56. PubMed ID: 36575535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epothilone D accelerates disease progression in the SOD1
    Clark JA; Blizzard CA; Breslin MC; Yeaman EJ; Lee KM; Chuckowree JA; Dickson TC
    Neuropathol Appl Neurobiol; 2018 Oct; 44(6):590-605. PubMed ID: 29380402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early and persistent abnormal decoding by glial cells at the neuromuscular junction in an ALS model.
    Arbour D; Tremblay E; Martineau É; Julien JP; Robitaille R
    J Neurosci; 2015 Jan; 35(2):688-706. PubMed ID: 25589763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Human-Based Functional NMJ System for Personalized ALS Modeling and Drug Testing.
    Guo X; Smith V; Jackson M; Tran M; Thomas M; Patel A; Lorusso E; Nimbalkar S; Cai Y; McAleer CW; Wang Y; Long CJ; Hickman JJ
    Adv Ther (Weinh); 2020 Nov; 3(11):. PubMed ID: 33709015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.